{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T18:43:14Z","timestamp":1785609794349,"version":"3.56.0"},"reference-count":26,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2022,2,14]],"date-time":"2022-02-14T00:00:00Z","timestamp":1644796800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Latvian Science Council","award":["lzp-2020\/2-0275"],"award-info":[{"award-number":["lzp-2020\/2-0275"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJNS"],"abstract":"<jats:p>New disease-modifying treatments have recently been approved for 5q spinal muscular atrophy (SMA) and early treatment has been associated with a better clinical outcome. Accordingly, new-born screening (NBS) for SMA should be implemented to ensure early diagnosis of affected individuals. The aim of this study was to determine the feasibility and usefulness of NBS for SMA in Latvia. Between February and November of 2021, 10,411 parents consented to participation in the study. DNA testing for the SMN1 exon 7 homozygous deletion was conducted using qPCR with fluorescent locked nucleic acid primers. In the first month of testing, reporting of results took up to a maximum of 17 days after samples arrived in the laboratory. However, following familiarisation with the procedure, the median report time was reduced to 11 days after birth. Forty cases required samples to be taken again due to poor quality of the isolated DNA transpiring from either the quality of the blood punch or manual mistakes during DNA isolation. The SMN1 exon 7 homozygous deletion was identified in two individuals, which was subsequently confirmed by multiplex ligation-dependent probe amplification. When a NBS sample is taken 48 to 72 h after birth and transported to the laboratory within two working days after collection according to legal requirements, DNA test results can be reported to healthcare professionals before the 12th day of life. Expansion of our SMA 5q NBS procedure to the whole of Latvia is feasible and would facilitate early diagnosis and result in more effective treatment. We strongly advocate that SMA is added to the national Latvia Recommended Uniform Screening Panel.<\/jats:p>","DOI":"10.3390\/ijns8010015","type":"journal-article","created":{"date-parts":[[2022,2,14]],"date-time":"2022-02-14T20:26:42Z","timestamp":1644870402000},"page":"15","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["New-Born Screening for Spinal Muscular Atrophy: Results of a Latvian Pilot Study"],"prefix":"10.3390","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7219-1294","authenticated-orcid":false,"given":"Linda","family":"Gailite","sequence":"first","affiliation":[{"name":"Scientific Laboratory of Molecular Genetics, Riga Stradins University, LV-1007 Riga, Latvia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Sterna","sequence":"additional","affiliation":[{"name":"Scientific Laboratory of Molecular Genetics, Riga Stradins University, LV-1007 Riga, Latvia"},{"name":"Clinic of Medical Genetics and Prenatal Diagnostics, Children\u2019s Clinical University Hospital, LV-104 Riga, Latvia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maija","family":"Konika","sequence":"additional","affiliation":[{"name":"Scientific Laboratory of Molecular Genetics, Riga Stradins University, LV-1007 Riga, Latvia"},{"name":"Clinic of Medical Genetics and Prenatal Diagnostics, Children\u2019s Clinical University Hospital, LV-104 Riga, Latvia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksejs","family":"Isakovs","sequence":"additional","affiliation":[{"name":"Scientific Laboratory of Molecular Genetics, Riga Stradins University, LV-1007 Riga, Latvia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jekaterina","family":"Isakova","sequence":"additional","affiliation":[{"name":"Scientific Laboratory of Molecular Genetics, Riga Stradins University, LV-1007 Riga, Latvia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2863-733X","authenticated-orcid":false,"given":"Ieva","family":"Micule","sequence":"additional","affiliation":[{"name":"Clinic of Medical Genetics and Prenatal Diagnostics, Children\u2019s Clinical University Hospital, LV-104 Riga, Latvia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Signe","family":"Setlere","sequence":"additional","affiliation":[{"name":"Clinic of Pediatric Neurology and Neurosurgery, Children\u2019s Clinical University Hospital, LV-104 Riga, Latvia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikus","family":"Diriks","sequence":"additional","affiliation":[{"name":"Clinic of Pediatric Neurology and Neurosurgery, Children\u2019s Clinical University Hospital, LV-104 Riga, Latvia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madara","family":"Auzenbaha","sequence":"additional","affiliation":[{"name":"Scientific Laboratory of Molecular Genetics, Riga Stradins University, LV-1007 Riga, Latvia"},{"name":"Clinic of Medical Genetics and Prenatal Diagnostics, Children\u2019s Clinical University Hospital, LV-104 Riga, Latvia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,2,14]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1186\/s13023-017-0724-z","article-title":"Indirect Estimation of the Prevalence of Spinal Muscular Atrophy Type I, II, and III in the United States","volume":"12","author":"Lally","year":"2017","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/1750-1172-6-71","article-title":"Spinal Muscular Atrophy","volume":"6","author":"Mercuri","year":"2011","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/s13023-017-0671-8","article-title":"Prevalence, Incidence and Carrier Frequency of 5q-Linked Spinal Muscular Atrophy\u2013A Literature Review","volume":"12","author":"Verhaart","year":"2017","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_4","unstructured":"\u0160etlere, S., Strautmanis, J., Rozent\u0101ls, G., Ozolina, G., Ber\u0137e, L., and Mi\u010dule, I. (2018). Spin\u0101l\u0101s Musku\u013cu Atrofijas Kl\u012bniski Epidemiolo\u0123iskais Raksturojums Latvij\u0101. Riga Stradins University Scientific Conference Abstract Book, Riga Stradins University."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Finkel, R.S., De Vivo, D.C., Swoboda, K.J., Bertini, E., Hwu, W.-L., Foster, R., Bhan, I., Fradette, S., and Farwell, W. (2020). Nusinersen in Infants Who Initiate Treatment in a Presymptomatic Stage of Spinal Muscular Atrophy (SMA): Interim Results from the Phase 2 NURTURE Study (993). Neurology, 94, Available online: https:\/\/n.neurology.org\/content\/94\/15_Supplement\/993.","DOI":"10.1212\/WNL.94.15_supplement.993"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.nmd.2019.09.007","article-title":"Nusinersen Initiated in Infants during the Presymptomatic Stage of Spinal Muscular Atrophy: Interim Efficacy and Safety Results from the Phase 2 NURTURE Study","volume":"29","author":"Bertini","year":"2019","journal-title":"Neuromuscul. Disord."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.nmd.2021.03.007","article-title":"Newborn Screening Programs for Spinal Muscular Atrophy Worldwide: Where We Stand and Where to Go","volume":"31","author":"Dangouloff","year":"2021","journal-title":"Neuromuscul. Disord."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"503","DOI":"10.3233\/JND-190428","article-title":"One Year of Newborn Screening for SMA\u2013Results of a German Pilot Project","volume":"6","author":"Vill","year":"2019","journal-title":"J. Neuromuscul. Dis."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jpeds.2017.06.042","article-title":"Presymptomatic Diagnosis of Spinal Muscular Atrophy through Newborn Screening","volume":"190","author":"Chien","year":"2017","journal-title":"J. Pediatr."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.3389\/fgene.2019.01255","article-title":"Newborn Screening for Spinal Muscular Atrophy in China Using DNA Mass Spectrometry","volume":"10","author":"Lin","year":"2019","journal-title":"Front. Genet."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.nmd.2019.02.003","article-title":"Newborn Screening for SMA in Southern Belgium","volume":"29","author":"Boemer","year":"2019","journal-title":"Neuromuscul. Disord."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/sj.ejhg.5200667","article-title":"Best Practice Guidelines for Molecular Analysis in Spinal Muscular Atrophy","volume":"9","author":"Scheffer","year":"2001","journal-title":"Eur. J. Hum. Genet."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.nmd.2017.11.005","article-title":"Diagnosis and Management of Spinal Muscular Atrophy: Part 1: Recommendations for Diagnosis, Rehabilitation, Orthopedic and Nutritional Care","volume":"28","author":"Mercuri","year":"2018","journal-title":"Neuromuscul. Disord."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.nmd.2018.01.003","article-title":"Correlation between SMA Type and SMN2 Copy Number Revisited: An Analysis of 625 Unrelated Spanish Patients and a Compilation of 2834 Reported Cases","volume":"28","author":"Calucho","year":"2018","journal-title":"Neuromuscul. Disord."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"e530","DOI":"10.1212\/NXG.0000000000000530","article-title":"Practical guidelines to manage discordant situations of SMN2 copy number in patients with spinal muscular atrophy","volume":"6","author":"Bernal","year":"2020","journal-title":"Neurol. Genet."},{"key":"ref_16","first-page":"147","article-title":"Neonatal Cystic Fibrosis Screening in Latvia: A Pilot Project","volume":"63","author":"Kornejeva","year":"2009","journal-title":"Proc. Latv. Acad. Sci. Sect."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41431-019-0476-4","article-title":"High-Throughput Genetic Newborn Screening for Spinal Muscular Atrophy by Rapid Nucleic Acid Extraction from Dried Blood Spots and 384-Well QPCR","volume":"28","author":"Czibere","year":"2020","journal-title":"Eur. J. Hum. Genet."},{"key":"ref_18","unstructured":"Lee, F., Cahhana, M., Comeau, A.M., Logerquist, K., Jones, D.E., Rohrwasser, A., and Baker, M. (2021, July 30). Spinal Muscular Atrophy: Overview of Available Screening Methods. Available online: https:\/\/www.newsteps.org\/sites\/default\/files\/resources\/download\/aphl_sma_webinar_slides_webinarslides_june2018_kh.pdf."},{"key":"ref_19","unstructured":"Mercer, K. (2021, July 07). ORISE Fellow Newborn Screening Translational Research Initiative Newborn Screening and Molecular Biology Branch Newborn Screening for Spinal Muscular Atrophy. Available online: https:\/\/www.aphl.org\/conferences\/proceedings\/Documents\/Mercer.pdf."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3201\/eid1002.030759","article-title":"Real-Time Reverse Transcription-Polymerase Chain Reaction Assay for SARS-Associated Coronavirus","volume":"10","author":"Emery","year":"2004","journal-title":"Emerg. Infect. Dis."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"111","DOI":"10.4236\/ojgen.2013.32014","article-title":"1000 Sample Comparison of MLPA and RT-PCR for Carrier Detection and Diagnostic Testing for Spinal Muscular Atrophy Type 1","volume":"3","author":"Strom","year":"2013","journal-title":"Open J. Genet."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"870","DOI":"10.3346\/jkms.2004.19.6.870","article-title":"Quantitative Analysis of SMN1 Gene and Estimation of SMN1 Deletion Carrier Frequency in Korean Population Based on Real-Time PCR","volume":"19","author":"Lee","year":"2004","journal-title":"J. Korean Med. Sci."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.nmd.2019.11.002","article-title":"244th ENMC International Workshop: Newborn Screening in Spinal Muscular Atrophy 10\u201312 May 2019, Hoofdorp, The Netherlands","volume":"30","author":"Dangouloff","year":"2020","journal-title":"Neuromuscul. Disord."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Romanelli Tavares, V.L., Monfardini, F., Louren\u00e7o, N.C., da Rocha, K.M., Weinmann, K., Pavanello, R., and Zatz, M. (2021). Newborn Screening for 5q Spinal Muscular Atrophy: Comparisons between Real-Time PCR Methodologies and Cost Estimations for Future Implementation Programs. Int. J. Neonatal Screen., 7.","DOI":"10.3390\/ijns7030053"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/s41436-019-0673-0","article-title":"The Implementation of Newborn Screening for Spinal Muscular Atrophy: The Australian Experience","volume":"22","author":"Kariyawasam","year":"2020","journal-title":"Genet. Med."},{"key":"ref_26","unstructured":"Strautmanis, J., Kenina, V., Setlere, S., Diriks, M., Millere, E., Micule, I., Lace, B., Kristapsone, G., Grantina, I., and Auzenbaha, M. (2022, February 01). Spinal Muscular Atrophy Expert Paper \u201cDiagnosis of Spinal Muscular Atrophy and Treatment Approach in Latvia\u201d. Clinical Guidelines of Latvian National Health Service, Available online: https:\/\/www.vmnvd.gov.lv\/lv\/media\/14120\/download."}],"container-title":["International Journal of Neonatal Screening"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2409-515X\/8\/1\/15\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:19:13Z","timestamp":1760134753000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2409-515X\/8\/1\/15"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,14]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,3]]}},"alternative-id":["ijns8010015"],"URL":"https:\/\/doi.org\/10.3390\/ijns8010015","relation":{},"ISSN":["2409-515X"],"issn-type":[{"value":"2409-515X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,14]]}}}